STAGE IIB ANAL CANCER AJCC V8
Clinical trials for STAGE IIB ANAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIB ANAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIB ANAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New trial tailors anal cancer treatment for people with HIV
Disease control OngoingThis phase 2 trial is testing whether adjusting treatment based on risk level can improve outcomes for people with HIV who have anal cancer. Low-risk patients receive standard chemotherapy and radiation, while high-risk patients also get the immunotherapy drug nivolumab after sta…
Matched conditions: STAGE IIB ANAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC
-
Immunotherapy after Chemo-Radiation may keep anal cancer at bay
Disease control OngoingThis study tests whether adding the immunotherapy drug nivolumab after standard chemoradiation helps prevent anal cancer from coming back in patients with high-risk stage II-IIIB disease. About 344 adults with squamous cell carcinoma of the anus are enrolled. Nivolumab boosts the…
Matched conditions: STAGE IIB ANAL CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 18, 2026 11:47 UTC